Julien Pham

Founder & Managing Partner, 3CC | Third Culture Capital

Role: Associate

Sites: CDL-Oxford, CDL-Seattle, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin

Streams: Advanced Therapies, Computational Health, Neuro

Julien Pham is a nephrologist and serial founder/entrepreneur interested in innovation and the impact of disruptive thinking and technology in the practice and delivery of modern medicine. Most recently, he was the president and chief operating officer of a publicly-traded clinical-stage biotech developing “21st century gene therapy for cancer.” Julien’s previous startup and academic experience include RubiconMD, RHINNO and Brigham iHub. At RubiconMS, Julien was a founder of the VC-backed health IT startup which prioritizes access to specialists for primary care communities. He built, qualified, and managed a vast network of top U.S. doctors to respond to e-consults. At RHINNO, Julien was a founder and manager of a rapid prototype/rapid deployment (lean) platform embedded within a large medical institution to strategically advance reciprocal innovation in the health IT field. Julien was on the founding committee of an academic incubator/accelerator, Brigham iHub, at a prestigious academic hospital in Boston